Q&A: Jeffrey L. Goldberg, MD, PhD — The Rise of Clinical Trials Centers of Excellence
Authors: Sheryl Stevenson, Jeffrey L. Goldberg, MD, PhD ｜ Published: July 24th, 2025
In this Q&A, Jeffrey L. Goldberg, MD, PhD, outlines how designated clinical-trials Centers of Excellence could streamline ophthalmic research by standardizing infrastructure, quality systems, and training across sites. He emphasizes that shared SOPs, interoperable data flows, and earlier engagement with regulators and payers can reduce start-up times, improve data integrity, and broaden access for patients and investigators alike.
Building on the CCOI collaborative model, Dr. Goldberg highlights priorities such as patient-centered endpoints, diverse recruitment, and integration of AI and real-world evidence into trial design. The aim is a scalable, equitable network that accelerates discovery while maintaining rigorous safety and effectiveness standards.
Audio interview • Press play to listen